
The FDA approved Fayuvi (rebisufligene etisparvovec-hopf), a one-time AAV9 gene therapy, as the first treatment for pediatric MPS IIIA (Sanfilippo syndrome type A).
With more than 8,000 members nationwide, NAPNAP is the professional association for pediatric nurse practitioners and other pediatric APRNs, including FNPs who treat children.
With more than 8,000 members nationwide, NAPNAP is the professional association for pediatric nurse practitioners and other pediatric APRNs, including FNPs who treat children. Whether you are a recent graduate or veteran provider, membership to NAPNAP is an essential tool for networking and enhancing your practice.






